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The human gut is home to a significant number of microorganisms including the dominant 
symbiont Bacteroides thetaiotaomicron. This microbe is predicted to possess an array of glycoside 
hydrolases, majority of which are involved in starch utilization. Presented here is a comparative 
functional analysis of two α-glucosidases, Family 31 Glycoside Hydrolases from Bacteroides 
thetaiotaomicron. Enzymatic kinetics revealed these enzymes both preferentially cleave α-(1,6) 
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1.1 Human-Microbial Interactions 
1.1.1 The Human Microbiome 
For centuries the complex interaction between humans and microorganisms has sparked interest in 
defining this intriguing relationship. The specifics of this relationship remain unclear; however, 
accumulating evidence demonstrates that these organisms are key components in our survival. From 
the moment we are born, we are exposed to an array of microorganisms and maintain this 
interaction throughout our life.  This indigenous microbiota can have weighty effects on our 
physiology and have been predicted to exceed the number of human cells ten to one
1
.  When 
assessing the physiological processes of humans it is not enough to only include our own specific 
functions, rather it would be beneficial to include those of our microbiota.   
The human body is a reservoir to a multitude of microorganisms and results in a highly diverse, 
specialized ecosystem. These organisms can be found in various areas of the body and primarily 
populating regions that are exposed to the exterior environment. Microbial colonization of these 
regions is specific for that niche and the interaction with the host is highly specialized. The 
relationship that exists between the human and its microbiota is one that generates numerous effects 
on both partners and is considered symbiotic
2
. Symbiosis is when two organisms reside in close 
contact with one another and is categorized as mutualistic, commensal or pathogenic. During the 
host’s lifetime the relationship with its microbiota can cycle between these three variants and is 
greatly influenced by diet, age and health
3
.  
1.1.2 Gastrointestinal Tract Microbiota and the Highly Populated Colon 
The gastrointestinal tract is specifically of interest because of the high number of microbial cells 




. Physiologically, the 
gastrointestinal tract is quite diverse with each region demonstrating characteristically distinct 
3 
 
environments, which reflects the resident microbiota (Figure 1.1). The pH varies significantly 
through the tract, ranging from 2.0 to 7.7 with gradual transitions from one region into another. The 
physical nature of the epithelium also varies along the tract with an evolution of smooth epithelium 
in the stomach, to significant crypts and microvilli in the small intestine and slightly decreased 
ridges in the walls of the colon.  
 
Figure 1.1 Physiology of the gastrointestinal tract.  The various regions of the gastrointestinal 
tract demonstrate differing physiological characteristics that can regulate the specific populations of 




In general, majority of the indigenous population resides in the small intestine and the colon, as a 
result of the physical attributes of these regions. More specifically, the total population observed in 
the colon represents more bacterial cells than the combined cells of all other regions of the human 
body, highlighting it as an ideal site to study and understand the interaction between 
microorganisms and the human host. It has been estimated that the colon has upwards of 10
11
 
microbial cells and characterized as one of the most densely populated regions in nature 
1
. A major 
influence on the microbial population of the colon is their ability to utilize substrates passing 
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through this region. The composition of the partly digested matter found in the colon is highly 
composed of indigestible polysaccharides as a result of upstream human digestive mechanisms. The 
majority of the ingested polysaccharides are degraded into simple sugars in the small intestine by 
action of the human luminal glycoside hydrolases, resulting in the low availability of simple sugars 
in the colon. Therefore, the substrates entering the colon are more apt to be complex sugars that the 
host is unable to degrade.  In order for an organism to reside in the colon, it must be able to utilize 
these polysaccharides that pass through or alternatively, have the ability to take up simple sugars 
that are released by surrounding microorganisms
6
. These undigested polysaccharides move very 
slowly at this point in digestion due to the limited fluidity in the colon. The combination of this with 




The colon microbial population is not only quite diverse but also the composition has been shown to 
be highly individualistic. It has been observed that there is a significant variation between 
individuals which is strongly reflective in the individual’s diet. This population is established by the 
creation of a specific equilibrium of substrates in the colon, which affects the competition between  
microbial populations
7
. A large component of the human diet is dietary fibre, the edible parts or 
component of plants or similarly related carbohydrates, which are resistant to human degradation 
and therefore are available for microbial breakdown
8
.  There are a multitude of physiological 
benefits from having a diet composed of these substrates. Benefits include an observed 
improvement in the functional mucosal layer of the epithelial, an environment that is conducive to 
the proliferation of intestinal microflora, an improvement in the balance between water and 
electrolytes and also a reduced glycemic response to hunger.  There is still a degree of ambiguity in 
the quantity of polysaccharides as provided by the host that is available for microbial digestion in 
the colon. However, measurements of diet composition at various regions of digestion have 
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suggested that 10 to 20% of an average meal of white bread in estimated to enter the colon and 
becomes available for microbial use
9
. Also, an indirect method of calculating bacterial cells in fecal 
samples and correlating that to required replenishment of the population and the amount of substrate 
to sustain such a population, demonstrated that an average of 15% of dietary sugar and starch enters 
the colon. In general it can be assumed that a minimum of 10% of the human diet of starch and 
sugar enter the colon and are considerably broken down by the indigenous microbiota.  This is a 
significant portion of the human diet that is unaccounted for and reveals that the large intestine is an 
important site to study the contribution the residing microbiota can have in nutrition
10
. 
A mutualistic relationship is highly evident in the colon between the microbes and the human host. 
The human host provides a habitat and a constant supply of nutrients to the microbes, while the 
microbes complete multiple functions that which the host cannot perform independently. 
Polysaccharides provided by the host through its diet are ideal sources for microbial energy 
acquisition by means of fermentation. The indigenous population ferments these substrates into 
functional small molecules which includes an excess of short-chain fatty acids. Butyrate is an 
example of a short chain fatty acid and has been shown as an energy source for the colonic mucosa; 
upwards of 95% of its production is absorbed across the epithelia of these cells. The conversion of 
these metabolites into short chain fatty acids is important for colonic health and has been shown to 
protect against colitis and colorectal cancer
11
. Specifically, it was shown that butyrate is capable of 
directly supressing colon cancer cell proliferation and subduing tumour growth in the large 
intestine
12
. Simply, the host provides polysaccharides through its diet to the microflora and in turn 




Figure 1.2 Balance in the colon. Various processes in the colon fluctuate the equilibrium in order 
to maintain a balance between with the host and the indigenous microbiota 
13
. 
Utilization of dietary plant polysaccharides results in an additional relationship to develop in the 
colon between cohabitating microbes. This relationship occurs by means of one population utilizing 
the host provided substrate and in the process providing additional substrates to the environment. 
This process is known as cross-feeding and results from a microorganism utilizing the primary 
substrate and with its cleavage results in the release of a smaller form, which can then be utilized by 
other microorganisms within the same population (Figure 1.3). This relationship nurtures a 
mutualistic interaction between these populations and further nurtures the one with the host. 
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Figure 1.3 Cross-feeding. Multiple levels of breakdown of the host’s diet  allow for a relationship 
between microbial populations, resulting in  sequestering substrates in order to obtain metabolites
7
. 
Composition of an individual’s microbiota is also dependent on environmental influences and 
genetic predisposition. Classifications of the composition of the colon microflora was completed by 
16S rRNA gene sequence-based enumeration and revealed significant diversity across the sampled 
pool. Over 17 phyla of Bacteria were detected with a surprising 90% of the phylogenetic types 
belonging to two main divisions, Firmicutes and Bacteroidetes
14
.   
 
1.2 Bacteroides thetaiotaomicron as a Dominant Symbiont of the Colon Microbiota 
Bacteroides thetaiotaomicron is an anaerobic gram negative bacterium that is part of the natural 
flora of the gastrointestinal tract. It was originally isolated from fecal samples in the process of 
isolating pathogens from the tract
15
. This organism is of interest due to its dominant presence in the 
colon microbiota and has been identified as a significantly player in the biological activities of this 
region. Bacteroides thetaiotaomicron is a member of the Bacteroidetes/Chlorobi superphylum, 
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Bacteroides has a significant evolutionary distance from other phyla, such as Proteobacteria and 
Firmicutes. This distance is highly illustrated in its genetic distinctness from these phyla
6
. 
Sequencing of Bacteroides thetaiotaomicron genome revealed this organism has highly distinctive 
genetic traits with a significant portion of its genome dedicated to the acquisition and utilization of 
polysaccharides. These characteristics exemplify how this organism is able to thrive in the highly 
populated intestinal ecosystem and is able to out-compete the other hundreds of species
16
.  
In general, the relationship between the host and Bacteroides thetaiotaomicron is a blend of 
mutualism and commensalism. It can be suggested that it is a mutualistic relationship based on this 
microorganism’s ability to utilize the dietary carbohydrates. This degradation ultimately results in a 
portion of these simple sugars being available in the lumen and is predicted to allow for the host 
epithelium to absorb these molecules, resulting in a contribution to the host energy intake
3
. Release 
of free sugars into the surrounding environment can also benefit other organisms in the intestinal 
population, which reveals a mutualism relationship between Bacteroides thetaiotaomicron and 




Figure 1.4 Bacteroides thetaiotaomicron’s role in the colon. The predicted role of Bacteroides 
thetaiotaomicron in colon includes polysaccharide utilization that produces simple sugars which 
can be utilized by the organism, by surrounding organism and absorbed by the human host. (Figure 
was reprinted with permission from AAAS and illustrator Katharine Sutliff) 
17
.  
However, it has not been empirically shown that this is the definitive role of this organism in the 
colon. It has also been hypothesized that the role of this organism is commensal and that its 
presence in this region of the body does not noticeably affect the human host.  
The distal region of the colon provides an environment that is conducive to the proliferation of 
Bacteroides thetaiotaomicron. The ascending portion of the colon has an approximate pH of 5.6 due 
to the rapid fermentation of short chain fatty acids by the residing microbial population. The 
absorption of these degraded fatty acids results in a considerably shift in pH to 6.6 in the distal 





. This organism has been identified as occupying this region of the colon in 
significant numbers yet defining the specific region of the distal colon that this organism occupies 
can be quite complicated due to the complexity of this environment. The colon has multiple 
surfaces in which Bacteroides can adhere, such as the lumen region, the mucosal layer and the 
epithelial surface. Despite crypts in the colon being significantly shorter than those in the small 
intestine, they can still provide a site for this organism to proliferate. Also, Bacteroides 
thetaiotaomicron are also able to form a stable environment on the substrates that pass through the 




1.3 Negative Influences Associated with Bacteroides thetaiotaomicron  
1.3.1 Colon Microbial Population as a Source of Antibiotic Resistance  
There are many roles that Bacteroides thetaiotaomicron plays in connection to the human host. It 
has been shown through a number of studies that microbes derived from the gut have the ability to 
have unfavourable effects on its host. Recent research has shown a correlation between post-surgery 
infections and microorganisms derived from this region. Treatment of these infections revealed 
these gut microorganisms possess various degrees of antibiotic resistance with an observed 
difficulty associated with treatment.  The specific contribution of Bacteroides thetaiotaomicron to 
such infections was investigated due to its dominance in the colon.  Genetic analysis revealed that 
Bacteroides thetaiotaomicron does have a significant role in this pathology and investigation of 
conjugative elements illustrated the basis for the observed resistance in this organism. Analysis of 
various samples specified that two resistant genes were observed, tetQ and ermF. The microflora of 
the colon is able to obtain these resistance elements via two postulated methods. Species that reside 
in the colon that possesses such elements are able to share them among other organisms of the same 
11 
 
population (Figure 1.5). Also, they can acquire these elements from microorganisms that do not 
primarily reside in this environment, but rather are passing through the gut and subsequently are 




Figure 1.5 Antibiotic resistant genes derived from the colon. Predicted method of bacterial 
strains obtaining antibiotic resistance occurs by transfer of restraint genes between Gram-positive 




1.3.2 Implications of Bacteroides thetaiotaomicron in Non-Gut Pathology 
Additional negative associations have been observed with Bacteroides species and their 
involvement in various human diseases. Observations of anaerobic infections and bacterial strains 
that reside in the infectious area revealed that the bacterium Bacteroides is one of the dominant 
participants. The most commonly associated infections with Bacteroides is intra-abdominal sepsis, 




































surgery leading to contamination of nearby tissues. This infection can arise from a surgical wound, 
appendicitis or malignancies with Bacteroides species colonizing in the later stages of the infection. 
Bacteroides species have also been shown to be implicated in bacteraemia, as the causative agent in 
the immuno-compromised and elderly. This infection stems from damage to mucosal barriers, 
which similarly, allows for this bacterium to remove itself from its common environment and 
colonize other regions. This organism has been classified as an opportunistic pathogen, yet the 
mechanism by which it relocates to other regions of the body demonstrates that it doesn’t act in 
such a manner. This gives the impression that this organism doesn`t take advantage of the weakened 
state of the host, rather appears to seek out additional sources of nutrition outside the gut. 
Bacteroides thetaiotaomicron gives the impression that it is highly commensal with its host if the 




1.4 Positive Associations of Bacteroides thetaiotaomicron in the Colon 
1.4.1 Bacteroides thetaiotaomicron and the Maturation of the Immune System 
Bacteroides thetaiotaomicron has also been highly implicated in positive associated interactions 
with the human host as demonstrated in the interaction with the colon immune system. The colon is 
an environment that is highly immune-competent, with direct interactions with the host’s immune 
system. It remains unclear as to why this highly populated region of the gastrointestinal tract is able 
to exist closely without bringing harm to the human. It has been predicted that the microbiota of the 
colon is an essential component to the development of the human’s immune system and these 
commensal organisms present specific factors that allow the host immune system to mature
20
. 
One speculation is that the indigenous population has specific factors on their cell surface that 
induce system maturation. Bacteria possess capsular and cell walls that are composed of 
13 
 
carbohydrates and have been shown to be recognized as antigens by the host’s immune system. 
These carbohydrate containing structures stimulate T-cells which in turn induce an IgM response. 
Researchers assessed the effect of inoculating germ-free mice with Bacteroides fragilis and 
observed the effects on the host’s immune system. Despite this study involving a single species that 
originates from a multispecies environment, it was relevant in showing that the presence of this 
bacterium had a positive effect on the mouse’s immune system. The presence of Bacteroides 
fragilis was adequate to facilitate a correction in CD4+T-cell defection in the spleen of the mice. 
Furthermore, it was found that a mutated strain of Bacteroides fragilis, was unable to elicit the same 
observed response, further demonstrating an important interaction between the host and its residing 
microbiota
21
. Though these results were observed with Bacteroides fragilis, this specie is strongly 
related to Bacteroides thetaiotaomicron, therefore, a similar interaction can be assumed to exist.  
Analysis of the effects of the microflora on the immune system revealed that Bacteroides species 
induced expression of antimicrobial molecules, which directly adhere and eliminate potential 
pathogens in the colon. Paneth cells are components of the lower gastrointestinal tract that produce 
granules containing antimicrobial proteins. These cells were evaluated by DNA microarray analysis 
in germ free mice and conventionally raised mice to observe changes in expression levels. It was 
observed that mice with an indigenous microbial population had an increased level of expression of 
a specific protein from the reg gene family. This secreted protein has a conserved carbohydrate 
recognition domain and previously was reported to be expressed during inflammatory responses 
during mucosal cells invasion. Purified Reg protein was demonstrated to bind significantly to 
peptidoglycan forms, commonly found on the surface of bacterial cells and indirectly affects the 
survival of pathogens. Evaluation of mice inoculated with Bacteroides thetaiotaomicron showed an 
increase in Reg expression; though it was not as high as conventionally raised mice that have a 
multispecies population. The presence of this indigenous population allows for the functioning of 
14 
 
the host immune system in the gut and specifically the cells found in the mucosal layer, and assist in 
immune functioning against pathogenic microorganisms
22
. 
Further evidence was demonstrated in the investigation of Ang4, a member of the human 
angiogenin protein family, which is commonly associated with the growth of the human tumour 
cells in mice. It was revealed that Ang4 is produced by Paneth cells secreted in to the gut lumen and 
was shown to have specific antimicrobial activity for intestinal microbes. Expression of this protein 
was found to be influenced by the presence of Bacteroides thetaiotaomicron, further supporting the 




The multitude of microbes residing in the brush border and microvilli of the colon wall also creates 
a physical limitation for invading microbes. The indigenous population limits the space available 
for pathogens to invade and colonize. The microbes that naturally reside in the colon are able to 
retain their position by having an interaction between the microbial polysaccharides that lie on the 
cell surface and the epithelial mucins. This mechanism allows these microorganisms to have a 
resistance to being washed away due to the peristaltic movements of the colon and thus lowering 
the chances of pathogens adhering. The presence of the microorganisms also triggers the release of 
granules of mucins, which in turn reinforces their adherence to the mucosal surface
24
. 
These studies support the idea that the presence of Bacteroides thetaiotaomicron in the colon 
contributes to the development and the maintenance of the human immune system. Specifically, the 
colonization of this organism in this region of body limits the invasion of foreign pathogens that 
ultimately can have a detrimental effect on the physiological state of the host.  
1.4.2 Probiotics and Prebiotics as Contributors to a Healthy Colon  
15 
 
The use of probiotics has been around for many years and recently has become an important tool in 
treating digestive illnesses. A probiotic is defined as a live microorganism that when consumed in 
significant quantities can have positive health benefits on the host
25
. Probiotics are commonly used 
to treat illnesses that include lactose intolerance, inflammatory bowel disease, and gastroenteritis, 
along with evidence to suggest that this treatment can influence the origin of colon cancer
26
. There 
are various mechanisms that probiotics can act in the gastrointestinal tract which influence the host 
and aide in restoring the colon to a healthy environment (Figure 1.6). Probiotic strains can colonize 
the epithelial surface and limit the physical available space for pathogens to adhere. They encourage 
goblet cells to produce mucus which limits the ability of pathogens to adhere to the epithelial 
surface. They allow for tight junction proteins to be unregulated, resulting in the limitation of 
unwanted pathogenic molecules to permeate the surface. Lastly, they are also capable of producing 
secreted molecules that hinder pathogenic strains from functioning normally
27
. 
It has also been observed that the presence of these probiotics in the colon can result in an increase 
in the amount of short chain fatty acids contributing to the maintenance of a healthy colon. Through 
animal studies it was also shown that probiotics can provide a protective barrier in the ridges 
between crypts and limit the colonization of pathogens. These are fundamental features of a healthy 
colon due to the presence of pathogens resulting in inflammation, which over time can lead to 
possible sites for digestive disorder development 
27
. 
Microbes from the gastrointestinal tract have been used for a number of years as probiotics. The 
most commonly used strains are lactic acid bacteria. However, recent evidence has demonstrated 
that probiotics that contain additional strains have positive effects on patients suffering from viral 
diarrhea. Studies involving Lactobacillus casei and Bacteroides thetaiotaomicron strains 
demonstrated modifications to cell surface glycans. Rotaviruses are observed to enter the cell by 
disturbing cell surface glycans, resulting in cell rupture and leading to gastroenteritis. Exposure of 
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intestinal cells to these bacterial strains results in strengthening the cell wall through modifications. 
Ultimately, the exposure of epithelial cells to these specific strains indirectly is able to lower the 
possibility of infection from rotavirus
28
. Utilizing strains specifically identified to be members of 
the colon microbiota can provide a less invasive method of treatment for individuals suffering from 
various digestive disorders.  
 A developing area of nutrition is the use of prebiotics for the maintenance of a balanced digestive 
tract. Prebiotics involve the ingestion of medical fibres, which are purified from their natural 
source, and in essence provide a substrate that can encourage the proliferation of the microflora of 
the gastrointestinal tract.  The effects of prebiotics have been shown to be very beneficial, 
demonstrating similar healthy effects as observed with consuming natural dietary fibre. Prebiotics 
are not to be used in replace of nutrition that provides natural dietary fibres, but rather should be 
used if an individual is limited by their diet, perhaps due to allergies or a gastrointestinal disorder
8
.  
There has been significant documentation reporting of the positive benefits prebiotics can have on 
individuals with type 2 diabetes and those suffering from heart disease. There is no specific 
evidence to show that prebiotics specifically promote the proliferation of Bacteroides 
thetaiotaomicron. None the less, it can be assumed that use of prebiotics can have a positive effect 
and provide a substrate that would encourage this bacterium’s proliferation. These reports further 
illustrate that nurturing the microbiota in the gastrointestinal tract can have profound positive 
effects on the individuals overall health.  
1.4.3 Bacteroides thetaiotaomicron and Inflammatory Bowel Diseases 
Bacteroides thetaiotaomicron has been observed to be associated with various inflammatory 
disorders of the gastrointestinal tract, such as Irritable Bowel Diseases (IBD), Irritable Bowel 
Syndrome (IBS) and Ulcerative Colitis (UC). These disorders are characterized as having 
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symptoms of abdominal pain, bloating and altered bowl movements.  Studies evaluating the gut 
microbiota and their interaction with these illnesses demonstrated a strong correlation in the 
composition of the flora and the observed symptoms
27
. Assessment of gene composition of the 
microbial population in the human gut revealed that individuals with IBD have 25% fewer genes in 
comparison with average individual
29
. A significant link was found to exist between the specific 
species that are present in the microflora of the gut and these illnesses, as shown through the 
evaluation of fecal bacterial composition in healthy individuals and those suffering from IBS and 
UC. There was an observed lower level of Bacteroides species in unhealthy individuals in 
comparison to the healthy controls
30
. This highlights the impact the microbiome can have on the 
human host and specifically the metabolic stability of the host’s digestive system. As previously 
highlighted, a poorly established bacterial population can result in inflammation of the colon 




1.5 Bacteroides thetaiotaomicron’s Influence on the Human Host’s Nutrition 
1.5.1 The Effect of Bacteroides thetaiotaomicron on Obesity  
The balance of energy in an individual is based on the intake of calories and the metabolic 
expenditure and storage. The main cause of obesity is an excess of caloric intake due to a highly 
functioning metabolism, but also generally due to an excess of provided nutrients. Obesity is of 
recent concern due to its increasing rate in developing countries. It has been characterized as an 
epidemic and has become a recent focus in nutritional research in reference to the functioning of the 
gastrointestinal tract
5
. Current research involving obese and lean mice revealed the composition of 
an individual’s gut microbiota can have a strong influence on an individual’s metabolic processes 
(Figure 1.6). It was observed that germ free mice inoculated with a distal gut microbiota community 
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from normally cultured mice demonstrated an increase in body fat. Over a period of 10-14 days it 
was found that the colonized mice had a significant increase in body fat during the period of limited 
food consumption. This study brings attention to a specific interaction between the gut microbiota 
and the host with an observed physiological consequence on the host. It was also revealed that the 
molecular level of this interaction involve the community of microbes fermenting the 
polysaccharides entering the distal gastrointestinal tract, leading to absorption of monosaccharaides 
and short chain fatty acids. These acids are then converted into complex lipids in the host’s liver 
and further regulate the transcription of host genes responsible for lipid disposition. Overall, this 
study lends to the hypothesis of obese individuals with a microbiota result in being more efficient at 
extracting energy from nutrients in comparison with lean individuals
31
. 
Characterization of the gene content of the gut microbiota was completed to further support the 
postulated link between the gut microbial community and obesity. Investigation of the distal gut 
microbiome of genetically obese, leptin deficient mice and the associated lean littermates was 
completed by metagenomic techniques. Additionally, obese and lean humans were assessed and 
genetic information of the same region of the microbiome was taken into account in the analysis. 
This type of comparative analysis defines a consistency between mice and human gut microbiome. 
Specifically, it was observed that the proportion of Bacteroidetes and Firmicutes correlates with the 
body mass index of the individual and the observed obese organisms from both groups have a 
significant decrease in the percent of Bacteroidetes
4
.  
Analysis of microbial communities from adult female monozygotic and dizygotic twin pairs of 
obese and lean physiology, as measured by 16S rRNA sequencing, addressed various influences on 
the gut microbiota, that include the host, genotype, environmental exposure and host adiposity. It 
was revealed that the gut microbiome is shared among family members but additionally it was 
shown that there is a ‘core’ microbiome at the gene level for all individuals. Results here also 
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support the understanding that obesity is associated with phylum-level changes of the microbial 
population in the gut and reduced bacterial diversity. An interesting link was found between the 
level of functional diversity in the microbiome and the abundance of Bacteoridetes
32
.   
 
  
Figure 1.6 Connection of the gastrointestinal microbiota with obesity. Various contributions 




Investigating the link between obesity and the host microbiota has revealed an interesting 
relationship, where in the case of obesity, a change in the microbiology of the gut can directly 
affects the host’s pathology
33
. Specifying this link also highlights a unique opportunity to have an 
active role in the health of obese individuals. The specific content of this region of the microbiome 
can possibly act as a ‘biomarker’ to indicate individuals who are predisposed to the development of 
obesity and furthermore, a therapeutic target for people already suffering from this disorder. Focus 
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association of  genetic and environmental factors  and how they influence on the composition of the 
gut microbiota that is specific for each individuals with obesity
34
. 
1.5.2 Starch Utilization by Bacteroides thetaiotaomicron 
Bacteroides thetaiotaomicron has also been highly implicated in having a strong effect on the 
metabolism of healthy individuals. It has been postulated that its presence in the colon directly 
impacts the utilization of various polysaccharides. Its contribution to nutrition has been investigated 
by the analysis of its growth requirements and it was revealed that it demonstrates the ability to 
make use of a variety of polysaccharides. Bacteroides thetaiotaomicron was observed to utilize 
polysaccharides that varied in length, as well as the composition of the sugar residues
35
. 
Specifically, it was found that this organism was able to grow on various profiles of starch
36
. 
Biochemical and genetic studies revealed that Bacteroides thetaiotaomicron possesses several genes 
that are fundamentally involved in the utilization of starch
37
. Investigation of the genes located near 
these identified starch genes revealed multiple outer membrane proteins involved in the binding and 
utilization of starch. Mutation studies further demonstrated that these proteins heavily influence the 
ability of this organism to utilize starch as an energy source
38
. This multiple protein system is 
collectively referred to as the Starch Utilization System (Sus) and has been stated to enable 




Figure 1.7 Starch Utilization System of Bacteroides thetaiotaomicron. This system has been 
characterized to consist of multiple proteins attached to the membrane that are able to bind and 
hydrolyze starch and export smaller oligosaccharides into the bacterial cell. These can then be 




The Sus system consists of an outer-membrane binding starch protein (Sus-D), membrane 
associated glucosidases (Sus-G, possible Sus-E and F), an outer membrane transporter that 
transports smaller oligosaccharides into the periplasm (Sus-C), a multiple periplasm associated 
glucosidases (Sus-A and B) and a transcriptional regulator (Sus-R) regulated by the released 
monosacchraides
39
. Crystal structures of Sus-D illustrated direct contact with β-cylcodextrin, 
identifying its involvement in the binding of starch
40
. Crystal structure of Sus-G, an α-amylase, 



























Understanding the details of Bacteroides thetaiotaomicron’s ability to utilize starch was explored 
by expression studies utilizing microarray analysis. Growth on glycan mixtures and analysis of the 
resulted expressed genes, demonstrated multiple loci involved in the utilization of these glycans. 
These genes were profiled and catalogued in Polysaccharide Utilization Loci (PUL), which 
consisted of multiple proteins involved in starch utilization with multiple homologs to Sus 
proteins
39
. Over 80 PUL’s were identified and characterized to contribute to Bacteroides 
thetaiotaomicron ability to utilize the provided polysaccharides and further supported the 




1.5.3 Family 31 Glycoside Hydrolases  
The ability of an organism to utilize carbohydrate molecules is defined by whether they possess 
enzymes that are capable of cleaving the bonds that make up the carbohydrate chain. These 
enzymes are known as glycoside hydrolases and are specifically characterized as catalyzing the 
hydrolysis of glycosidic linkages releasing simple sugars
43
. These glycoside hydrolases are 
classified into over 100 families by their specific enzymatic functionality, related substrate 
specificity and amino acid composition. These families encompass a wide range of capabilities 
along with various preferred substrates
44
.  
Family 31 is a glycoside hydrolase family that is relevant to nutrition as a result of it being one of 
two families that has been shown to demonstrate α-glucosidase activity and indicated to be involved 
in the degradation of starch polymers. Human Family 31 enzymes have been investigated due to 
their significant contribution to human digestion and have been shown to be specifically involved in 
starch digestion. These enzymes, maltase-glucoamylase (MGAM) and sucrase-isomaltase (SI) 
contain four α-glucosidases that are part of two small intestinal membrane bound enzymes with 
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multiple activities of maltase and sucrose isomaltase. These enzymes are composed of duplicate 
domains and have been characterized as contributing to metabolism from the human diet by the 
cleavage of starch into individual glucose units that are utilized for energy
45
.  A variety of enzymes 
are members of Family 31, however, α-glucosidases are the primary enzymes of interest in relation 
to digestion. Family 31 α-glucosidases are endo-acting enzymes and are predicted to act on the 
terminal non-reducing end of starch polymers, resulting in the release of free glucose
44
. The specific 
mechanism of this family is the retaining mechanism, which was first proposed by Koshland
46
. The 
retaining mechanism involves two successive nucleophilic substitutions at the anomeric center 
(Figure 1.8). The first step is the nucleophilic residue acting on the anomeric center by the 
assistance of a second residue acting as an acid, creating the glycosyl-intermediate. In the second 
step, the deprotonated acidic residue, acts as a base and accepts a hydrogen ion from a water 




Figure 1.8 Retaining enzymatic mechanism. The predicted mechanism of Family 31 Glycoside 
Hydrolases is the retaining mechanism
48
. 
Multiple families utilize this specific mechanism in their hydrolysis of substrates, yet the defining 
characteristics of Family 31 Glycoside Hydrolases is the residues involved in the cleavage of the 
substrate, specifically characterized as aspartate residues.  
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Interestingly, both Bacteria and Eukaryotes possess enzymes that have been predicted to be 
members of Family 31. These organisms are distinctly different and overall homology is quite low, 
however, some of these enzymes have a common signature sequence (Figure 1.9). This brings 
attention to the idea that though there is limited similarity in the sequence of these enzymes, they 
may have a common functionality. 
 
Figure 1.9 Signature sequence of Family 31 α-glucosidases. A comparison across kingdoms of 
Family 31 α-glucosidases reveals a fairly consistent signature sequence. NT-MGAM, NT-SI, CT-
MGAM and CT-SI are human enzymes, MalA is a from Sulfolobus solfataricus, R.obeum is an 
enzyme from Ruminococcus obeum, YicI is from Escherichia coli and BT_3299, BT_3086 and 
BT_0339 are from Bacteroides thetaiotaomicron.  
 
1.5.4 Family 31 Glycoside Hydrolases from Bacteroides thetaiotaomicron 
 Sequencing the genome of Bacteroides thetaiotaomicron revealed a significant percentage of its 
genome dedicated to glycoside hydrolases
1
. In comparison with other members of the colon 
microbiota, it is demonstrated that Bacteroides thetaiotaomicron possess an advantageous number 
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of these carbohydrate enzymes which possibly reflects the dominate role it has in this region of the 
gastrointestinal tract (Figure 1.10). 
 
Figure 1.10 Comparison of predicted glycoside hydrolases. Comparison of predicted glycoside 
hydrolases with common members of the colon microbiota demonstrates Bacteroides 
thetaiotaomicron has an advantageous number over these other microorganisms
44
. 
In comparison to other microorganisms found in the gut, Bacteroides thetaiotaomicron has a greater 
number of Family 31 Glycoside Hydrolases, with three predicted α-glucosidases. These enzymes 
are predicted to utilize starch as part of its metabolism and release free glucose, which can be 

















































































































information on the ability of these enzymes to contribute free glucose to the host at comparable 
levels of the human forms of these enzymes. Understanding the functionality of these enzymes can 
also provide some comprehension of a process that is predicted to readily occur in Bacteroides 
thetaiotaomicron.  
1.6 Focus of Family 31 Glycoside Hydrolases from Bacteroides thetaiotaomicron 
The objective of this research was to express a recombinant Family 31 Glycoside Hydrolase, an α-
glucosidase, from Bacteroides thetaiotaomicron. This study incorporated the assessment of this 
enzyme and its ability to hydrolyze a range of substrates, which are derivatives of starch, a common 
component of the human diet. The goal was to provide an understanding of how this specific 
enzyme functions within the human gut and observe its predicted contribution to human nutrition. It 
was hypothesized that this enzyme is an α-glucosidase which is able to contribute to the digestion of 
starch-derived substrates by liberating free glucose that indirectly can be utilized by the host. This 
study highlights an area of research that can provide insight into the complex commensal 
environment that resides within the human intestines that can profoundly affect the host’s diet and 
nutrition. 
The research proposed here will build upon past research by investigating a probable glycoside 
hydrolase from Family 31 Glycoside Hydrolase derived from the organism Bacteroides 
thetaiotaomicron. BT_0339 is the specific α-glucosidase that is focused on in this study with the 
purpose of defining its functional capabilities in-vitro. This enzyme has an observed limited 





Figure 1.11 Comparison between Family 31 Glycoside Hydrolases from Bacteroides 
thetaiotaomicron. Signature sequence comparison across this family for Bacteroides 
thetaiotaomicron reveals that there are distinct differences amongst this family. 
 
However, BT_0339 was compared across Bacteroides species and it was found that there was a 
significant sequence similarity and the signature sequence was consistent (Figure 1.12). This 
indicates that there is a consistent enzymatic function that has been retained across this genus and 
preserved during evolution and may contribute to the specific niche of the gut microbiota. 
Therefore, the proposed hypothesis in this study is relevant to other predicted family 31 α-
glucosidases in other members of Bacteroides. 
 
 
BT3086          ISGFWTDMGEPAWSN-------- 
BT3299          DGVWNDVNEPQINDTPNKT 
BT3659          DAWWLDSTEPDHMD------ 
BT0339          VTCIKTDFGENIHMD---------- 
BT3169          VRVLKTDVAWVGAGY--------- 




Figure 1.12 Comparison of Family 31 α-glucosidases from Bacteroides species. Signature 
sequence comparison between Bacteroides species found in the colon results in a highly conserved 
sequence. 
Additionally, a previously expressed and purified α-glucosidase, BT_3299
49
, that is also a member 
of Family 31, was assessed in this study. The understanding of the functionality of this enzyme can 
contribute to the evaluation of BT_0339 and to the comprehension of how Bacteroides 





Bacteroides ovatus                 VTCIKTDFGENIHMDALYKGMKPELLNN  
Bacteroides xylanisolvens             VTCIKTDFGENIHMDALYKGMKPELLNN  
Bacteroides thetaiotaomicron  VTCIKTDFGENIHMDAVYKGMKPELLNN  
Bacteroides dorei                VTCIKTDFGENIHMDALYKGMKPELLNN 









2.1 Expression System for bt_0339 
The Novagen pET System was the selected expression system, a commonly used instrument in 
protein expression. This specific system allows for the expression of the gene of interest under the 
control of a highly effective bacteriophage T7 transcription and translation signals
50
. Two vectors 
were selected from this system, allowing for the expression of two forms of the protein, providing a 
degree of flexibility with the protein product. The pET-29a was the initial vector selected and 
contains a C-terminus purification His-tag, Kanamycin resistance as a selectable marker and a 








Figure 2.1 pET-29a vector. a) Vector map b) cloning/expression region. (Picture was reproduced 






pET-15b was also selected as an expression vector and contains a N-terminus purification His-tag, 
Ampicillin resistance as a selectable marker and a multiple cloning site (Figure 2.2). Alteration in 
the location of the His-tag (N-terminus or C-terminus) will result in a slight variation in the 






Figure 2.2 pET15b vector. a) Vector map b) cloning/expression region. . (Picture was reproduced 








2.2 Cloning of the gene bt_0339 
Genomic DNA of Bacteroides thetaiotaomicron-VPI 5482 was purchased from ATCC. The 
predicted gene bt_0339 was amplified from the genomic DNA by polymerase chain reaction (PCR) 
with primers designed with two restriction sites (Table 2.1).  Primers contained an NdeI and XhoI 
cut site for the forward and reverse respectively and align with the same cut sites in the expression 
vector.  
 
Table 2.1 Primers used for cloning of BT_0339. Underlined region indicates the restriction site. 
Primer Sequence (5’-3’) Restriction Site 





The PCR protocol consisted of denaturation at 98°C for 10 sec, annealing at 62°C for 30 sec and 
extension at 72°C for 1 min, for 35 cycles. PCR product was purified, digested and ligated into the 
two respective vectors. Constructs were transformed into Escherichia coli strain, DH5α. Screening 
of colonies for the vector with the desired insert was completed by purification of the vector, 
digestion with a single restriction enzyme and screening by electrophoresis for an increase in vector 
size proportional to the insert. Confirmation of the insert was completed by DNA sequencing with 
primers specific for the T7 site in the vector and was completed in both forward and reverse 
directions. 
 
2.3 Expression of α-glucosidase gene bt_0339  
The pET-29a plasmid, containing bt_0339 (BT_0339-29a) was transformed into an Escherichia coli 
Rosetta (DE3) pLysS strain, a highly stringent expression strain containing a chromosomal copy of 
the gene T7 RNA polymerase and Chloramphenicol resistance as a selectable marker. In order to 
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obtain high transformation efficiency, transformation was completed with freshly prepared 
competent cells. Cultures were plated on LB-agar plates with both selective antibiotics. A single 
colony was used to inoculate LB broth with the appropriate antibiotics and grown overnight. Small 
scale expression was initiated by using this overnight culture to inoculate fresh LB broth with the 
appropriate antibiotics and grown to an OD590 reading of approximately 0.4 at 37°C. Expression of 
T7 RNA polymerase was induced through the addition of isopropyl-beta-D-thiogalactopyranoside 
(IPTG) for a final concentration of 1mM.  Cell pellet was re-suspended in lysis buffer (50mM 
NaH2PO4 and 300mM NaCl) and cells were lysed by repeated rounds of sonication. The cell free 
extract and lysed cells were run on a SDS-PAGE for confirmation of the expressed protein, which 
was ~87,000 Daltons in size. Optimization of expression was completed by varying the expression 
time period, incubation temperature and the final concentration of IPTG.  
  
The optimized conditions were then used in a large scale expression. Large scale expression was 
completed with incubation at 37°C until an OD595 of 0.4 was reached, induced expression by the 
addition of IPTG at a final concentration of 50μM and expression in an overnight time period at 
30°C.  Cell pellet was re-suspended in 200ml of lysis buffer and cells were emulsified at 30psi for 
three rounds. 
 
Expression was also completed with the construct in the vector pET-15b (BT_0339-15b). Small 
scale optimization of expression was completed in the same manner as with BT_0339-29a. The 
optimized conditions for this expression were incubation at 37°C until an OD595 of 0.4 was reached. 
Expression was then induced by the addition of IPTG at a final concentration of 500μM and 
incubated overnight at 30°C. Cell pellet was re-suspended in 200ml of lysis buffer and cells were 





2.4 Purification of BT_0339  
Affinity chromatography was the first step in the purification of BT_0339-29a. The 6xHis-tag that 
is adjacent to the recombinant protein was the tool utilized in this chromatography which has a high 
affinity for the nitrotriacetic acid chelating resin that is charged with nickel ions. Small scale 
purification was completed and fractions were run on an SDS-PAGE to determine the optimal 
elution that the protein of interest eluted off the column. Full purification was completed in a batch 
incubation of the lysed cells with NTA-Ni resin slurry in a ratio of one part resin slurry and ten 
parts lysed cells. Protein/resin slurry was incubated overnight with rotation at 4°C. Slurry was then 
packed into a column for gravity flow purification. The packed column was washed twice with 
wash buffer (50mM NaH2PO4, 300mM NaCl and 10mM imidazole, pH 8.0) and the protein of 
interest was eluted off in a concentration gradient of imidazole (25-250mM). Fractioned elutions 
were collected in 1ml volume for the optimized elution. The pooled elution was desalted into a 
stable buffer (20mM Tris-HCl, pH 7.5). This step prevents the protein from salting out of solution 
in the presence of high amounts of imidazole and allows the protein to be in a compatible buffer for 
the next step of purification. To ensure the protein solution is homogenous, an additional 
purification step was required. Fast Protein Liquid Chromatography (FPLC) purification was 
completed with the use of an anion exchange column, allowing for the separation of contaminates 
that are in close size to BT_0339 by utilization of the different isoelectric points of these proteins. 
The selected pH range for the buffer for the purification with this specific column and protein was 
Tris-HCl, pH 7.6-8.6, due to the pI of BT_0339 being 5.7.  Protein solution was loaded onto the 
column and eluted off in a concentration gradient of 1M NaCl from 0-100%. Fractions with an 
indication of protein were assessed by SDS-PAGE to ensure the fractions to be pooled did not have 




Confirmed fractions from a slender peak on the FPLC absorbance of 280nm were pooled and a 
buffer exchange was completed in order to remove residual NaCl. The final working solution was 
then concentrated to reach the desired working concentration in the range of >5mg/ml. Other 
fractions that had remaining amounts of the protein of interest were then pooled and used for 
enzyme assays.  
 
 Confirmation of the isolated protein was completed to ensure it corresponds to the predicted α-
glucosidase prior to initiation of the enzyme assays and crystallization trials. A sample was sent to 
the Aims Laboratory at the University of Toronto where they completed Mass Spectrometry-
Electron Ionization. This specific method vaporizes the protein to produce ions and then the 
analyzer determines the mass to charge ratio. The detector then records the occurrence of these ions 
and reports the overall the mass
51
. This estimated mass can then be compared to the predicted mass 
that was calculated from the amino acid sequence of the enzyme.  
 
Purification was completed for BT_0339-15b in the same manner as with BT_0339-29a 
 
2.5 Substrate Specificity of BT_0339 
Substrate specificity is an important characteristic to define for the enzyme of interest and can lead 
to an understanding of its function and structure. A variety of substrates were assessed using a 
standardized method, glucose oxidase assay. This assay evaluates the enzyme’s ability to utilize the 
provided substrate and release free glucose in solution. This free glucose arises from its cleavage 
from the provided substrate and colour development occurs with the addition of the glucose 
oxidase/peroxidase reagent. The free glucose reacts with the glucose oxidase reagent, producing 
hydrogen peroxide which in turn, reacts with peroxidase. Reaction with peroxidase produces a 




Substrates evaluated were maltose, isomaltose, maltotriose, maltotetraose, maltopentaose, 
maltohexaose, maltoheptaose, sucrose and lactose. Maltose was the initial substrate assessed as a 
result of the predicted substrate specificity for BT_0339. Optimization of maltose allowed for the 
determination of the concentration range that allowed for a complete enzymatic curve to be 
calculated. All enzyme assays were completed with the enzyme BT_0339-29a and at a final 
concentration of 10nM and at a pH of 6.5. The assay reaction consisted of 40μl of maltose solution, 
10μl of enzyme at 10nM and 0.1mg/ml of BSA.  Assay was incubated at 37°C for 45 min and then 
the reaction was quenched by the addition of 3M Tris, pH 6.9. The reaction was developed by the 
addition of 125μl of Glucose Oxidase reagent and incubated at 37°C for 30 min. Absorbance of the 
reactions were assessed by a spectrometer at 450nm. A glucose standard curve was completed 
alongside each assay for quality control and to determine the amount of liberated free glucose for 
each reaction.  
Reactions were completed in a minimum of triplicates and incubated in a range of substrate 
concentration from 2mM to 200mM. There were limitations with the quantitative availability of 
some of the substrates, resulting in these assays having a maximum substrate concentration of 30 to 
50mM. 
 
To ensure the location of the His-tag was not interfering with the functioning of the enzyme, an 
assay with maltose was completed with the enzyme BT_0339-15b. Concentration of maltose 
assessed was also 1-200mM. The pH of the assay was also assessed to determine if this is a 
significant variable affecting the enzymes functionality. The assay was completed in the same 
manner as previously described, yet the maltose solution was assessed in a pH range of 5.5 to 9.0 




Kinetics of the enzyme BT_0339 was determined using the program KalediaGraph4.1. The program 
was used to fit the data to the Michaelis-Menten equation (Figure 2.3).  
 
 





2.6 Additional α-glucosidase, BT_3299  
An additional α-glucosidase, BT_3299, was also assessed in the same manner as BT_0339. The 
construct was generated in a previous experiment and expression and purification was previously 
optimized
49
.  Transformed expression cells containing the construct for BT_3299 in the vector pET-
29a were grown overnight. The overnight culture was used to inoculated LB broth and incubated at 
37°C until an OD595nm of 0.6 was reached. Expression was induced by the addition of IPTG for a 
final concentration of 400μM and grown overnight at 30°C. Pelleted cells were re-suspended in 
lysis buffer and emulsified at 30psi for three rounds. 
 
Purification of BT_3299 was initially completed in the same manner as BT_0339 by affinity 
chromatography. Elution fractions were pooled, desalted and purified additionally by FPLC on an 
anion exchange column. Fractions from this stage were pooled and buffer exchanged completed 
into 20mM Tris, pH 8.0. Solution was concentrated to a final working concentration of >5mg/ml, 
which was used in crystallization trials and enzyme assays. 
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Substrate specificity was assessed in the same approach as completed for BT_0339. Assays were 
completed at a final concentration at 10nM and data was fit to the Michaelis-Menten equation in 
KalediaGraph.  
 
2.7 Operon Prediction for BT_0339 and BT_3299 
The operon that the genes bt_0339 and bt_3299 are members of was investigated by use of the 
MicrobeOnline Database. This database functions by connecting functional genomic data with 
comparative genomic analysis
53
. The outputted data is based on a method where operons are 





2.8 Crystallization Screening for BT_0339 and BT_3299 
Once each enzyme was purified to sufficient homogeneity, the conditions under which it can be 
crystallized were investigated. Sitting Drop Vapor Diffusion method was used in the preliminary 
crystallization screening. Hampton Index Screen
55
 was the initial screen used to narrow the 
conditions of crystallization. Results from this screen can be used to determine a set of conditions to 
optimize the crystallization conditions. BT_0339-29a was screened at 5mg/ml, BT_0339-15b was 
screened at 7mg/ml and BT_3299 was screened at 5mg/ml. Screen consisted of 100μl reservoir 
solution and a 2μl drop in a ratio of 1:1 protein and reservoir. These plates were incubated at room 
temperature and were observed daily for crystallization. Conditions that demonstrated conditions 
that allowed for crystallization were further optimized with custom made screens that include 












3.1 Amplification of bt_0339 gene by Polymerase Chain Reaction 
The gene bt_0339 from Bacteroides thetaiotaomicron was successfully amplified by Polymerase 
Chain Reaction (PCR). The amplified product was run on a 1% agarose gel for confirmation of the 
size of the amplified fragment (Figure 3.1).  
   
Figure 3.1 Amplification of bt_0339 by Polymerase Chain Reaction. Lane 1 was the DNA ladder 
and lane 2 is the amplified product of bt_0339. 
 
The expected size of the amplified product was ~2300 base pairs as confirmed by comparison with 
the DNA ladder. Cloning was completed successfully and constructs for both vectors were 








Figure 3.2 Alignment of protein sequence as confirmed by DNA sequence of bt_0339 
constructs. Alignment was completed for both constructs in comparison with the predicted amino 
acid sequence for BT_0339.  Dark coloured region indicates the amino acid deduced from 
confirmed DNA sequence and the light region is the amino acids that are unknown.  Clone Bt-29-
2.2 contains the construct in vector pET-29a and clone Bt-15-20.3 contains the construct in vector 
pET-15b. 
A large proportion of the gene was successfully sequenced with approximately 70% coverage of the 
sequence for the protein of interest. This was adequate amount of information regarding the 
constructs in order to move on to the next stage of this study. 
3.2 Expression of BT_0339 in pET-29a vector 
Initially the optimal temperature for expression of BT_0339-29a construct was assessed in a small 
scale format. Cultures were grown at 37°C until an OD595 of 0.4 was achieved and then the culture 
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was induced with IPTG for a final concentration of 1mM and grown overnight at 37°C, 30°C and 
20°C. Soluble and insoluble fractions were compared on an SDS-PAGE (Figure 3.3). 
 
 
Figure 3.3 Optimization of temperature for the expression of BT_0339-29a. Lane 1 is a protein 
ladder, lane 2 is the control (uninduced), lanes 3 and 4 are induction at 37°C, supernatant and pellet 
respectively, Lanes 5 and 6 are induction at 30°C, supernatant and pellet respectively, and lanes 7 
and 8 are induction at 20°C, supernatant and pellet respectively. 
It was demonstrated that the temperature that provided the highest degree of expression of the 
protein of interest was 30°C. At this given temperature there is minimal amount of insoluble protein 
and a high degree was soluble protein.  
Additionally, temperature for expression was also optimized for BT_0339-15b construct. 
Expression was completed overnight at 37°C, 30°C and 20°C. Soluble and insoluble fractions were 
run on an SDS-PAGE for comparison (Figure 3.4) 
 





Figure 3.4 Optimization of temperature for the expression of BT_0339-15b. Protein of interest 
was expressed at 37, 30 and 20°C.  Lane 1 is the protein ladder, lane 2 and 3 is 37°C, insoluble and 
soluble fractions respectively, lane 4 and 5 is 30°C, insoluble and soluble fractions respectively, and 
lanes 6 and 7 is 20°C, insoluble and soluble fractions. 
It was found that 30°C was also the optimal temperature for expression of BT_0339-15b. At this 
given temperature there was a significantly higher degree of expressed protein which was soluble.  
The length of time of expression is a variable that can have a powerful effect on the level of protein 
expressed and therefore was investigated for BT_0339. BT_0339-29a was expressed at various time 
intervals and soluble fractions were run on an SDS-PAGE for comparison (Figure 3.5). 




Figure 3.5 Optimization of the length of incubation for the expression of BT_0339-29a. Lane 1 
is the protein ladder, lane 2 is 1hr, lane 3 is 2 hr, lane 4 is 3 hr, lane 5 is overnight and lane 6 is 5 hr.  
It was revealed that the optimal length of incubation required for a high level of expression was 
overnight. This amount of time produced a good level of soluble protein in comparison with the 
other fractions. 
The amount of time required for expression was also optimized for BT_0339-15b vector. The 
construct was expressed at various time intervals and the soluble fractions were run on an SDS-
PAGE for comparison (Figure 3.6) 
 
 




Figure 3.6 Optimization of the length of incubation for the expression of BT_0339-29a. Lane 1 
is the protein ladder, lane 2 is a control (no induction), lane 3 is 30 min, lane 4 is 1hr, lane 5 is 2hr, 
lane 6 is 3hr, lane 7 is 5hr and lane 8 is overnight.  
The length of time appeared to not have a significant impact on the level of expression of BT_0339-
15b. Therefore, overnight expression was selected as the preferred expression time period due to 
technical aspects. 
The amount of IPTG required for induction was also optimized. Highly levels of IPTG have been 
reported to be correlated with high levels of bacterial host proteases with ultimately lead to 
degradation of the protein of interest
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. Lowering the level of IPTG without having a dramatic effect 
on the level of protein expressed can be beneficial. BT_0339-29a was grown at 37°C until an OD595 
of 0.4, followed by induction with various levels of IPTG.  These cultures were grown overnight 
and observed by running the cell lysates on an SDS-PAGE for comparison (Figure 3.7). 
 




Figure 3.7 Optimization of IPTG for the expression of BT_0339-29a. Lane 1 is the protein 
ladder, lane 2 is a control (uninduced), lane 3 1mM IPTG, lane 4 is 500μM, lane 5 is 100μM, lane 6 
is 50μM and lane 7 is 10μM.  
It was observed that a final concentration of 100μM IPTG in the media had little effect on the level 
of expressed protein. At this concentration of IPTG, there were still significant levels of protein 
expressed in comparison to the control. 
The amount of IPTG required to induce the expression of the desired protein was also tested with 
the construct in vector pET-15b. Analysis was completed by running cell lysates on an SDS-PAGE 
for comparison (Figure 3.8). 
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Figure 3.8 Optimization of ITPG for the expression of BT_0339-15b. Lane 1 is the protein 
ladder, lane 2 is 1mM, lane 3 is 500μM, lane 4 is 100μM, lane 5 is 50μM and lane 6 is 10μM of 
IPTG. 
A final concentration of 100μMof IPTG provided was shown to induce a reasonable level of 
expression. In comparison to the additional samples, this level of IPTG allows for limited 
degradation an sufficient soluble product.  
3.3 Affinity Purification of BT_0339  
BT_0339 was purified by affinity chromatography by use of Ni-NTA resin. This resin has a strong 
affinity for the His-tag that resides on either end of BT_0339 constructs. Purification of BT_0339-
29a was completed in a packed column at ambient pressure with elution by an imidazole gradient. 
Fractions were retained and collectively ran on an SDS-PAGE for analysis (Figure 3.9) 




Figure 3.9 Affinity purification of BT_0339-29a with Ni-NTA resin. Lane 1 is a protein ladder, 
lane 2 is the flow through, lane 3 is wash 1, lane 4 is wash 2, lane 5 is 25mM imidazole, lane 6 is 
50mM imidazole, lane 7 is 100mM imidazole, lane 8 is 200mM imidazole and lane 9 is 250mM 
imidazole elutions. 
Majority of BT_0339-29a came off at the elution containing 100mM of imidazole. There was a 
degree of BT_0339 that came off in the additional elutions; however, these fractions may consist of 
BT_0339 in slightly different conformations, which is undesirable for crystallization. It can also be 
observed that there was some non-specific proteins that bound to the column, which were also 
eluted at the 100mM elution and as a result will need to be further purified to remove these 
containments. 
Affinity purification was also completed with BT_0339-15b construct with the same method 
(Figure 3.10). 




Figure 3.10 Affinity purification of BT_0339-15b with Ni-NTA resin. Lane 1 is the protein 
ladder, lane 2 is the flow through, lane 3 is wash1, lane 4 is wash 2, lane 5 is 25mM imidazole, lane 
6 is 50mM imidazole, lane 7 is 100mM imidazole, lane 8 is 200mM imidazole and lane 9 is 250mM 
imidazole elutions.  
It was observed that the elution of 100mM imidazole demonstrated the highest amount of desired 
protein coming off the column. Similarly, there were some undesirable products eluted off the 
column in the same fractions as BT_0339-15b, which revealed this elution required further 
purification prior to crystallization trials.  
3.4 FPLC Purification with Anion Exchange Column 
A buffer exchange was completed in order to remove the imidazole from the pooled elution and was 
followed by an additional purification step. An anion exchange column was utilized and protein 
elution was detected at an absorbance of 280nm (Figure 3.11). 
 




Figure 3.11 FPLC Purification of BT_0339-29a by anion exchange. Outlined region indicates 
the fractions that were pooled. 
It was observed that there was a desirable amount of protein that was eluted off the anion column. 
Fractions 21 to 26 were pooled and are assumed to be the protein of interest. The pooled product 








Figure 3.12 SDS-PAGE analysis of FPLC purification fractions for BT_0339-29a. Lane 1 is a 
protein ladder, lane 2 is fraction 21-26, lane 3 is fraction 27, lane 4 is fraction 28, lane 5 is the 
pooled fractions 29 and lane 6 is fraction 20.  
 
SDS-PAGE analysis of the pooled fractions from the FPLC purification revealed the pooled sample 
did contain the protein of interest and an improvement in the sample homogeneity.  There was a 
faint band below the protein of interest; however, it still appears that this protein is worth pursing 
for crystallization trials. 
BT_0339-15b was also purified in an additional step by FPLC by use of an anion exchange column. 
This step of purification was completed in the same manner as for BT_0339-29a (Figure 3.13). 




Figure 3.13 FPLC Purification of BT_0339-15b by anion exchange. Fractions that contained 
protein and that were subsequently pooled are highlighted. 
A significant quantity of BT_0339-15b came off the anion exchange column in the FPLC 
purification. Fractions 21 to 26 were pooled and run on an SDS-PAGE for confirmation of 
purification, along with additional fractions with detected protein (Figure 3.14). 
 
Figure 3.14 SDS-PAGE analysis of FPLC purification fractions for BT_0339-15b. Lane 1 is the 
protein ladder, lane 2 is pooled fractions 21 to 26, lane 3 is fraction 20, lane 4 is fraction 27 and lane 
6 is fraction 28.  
  1    2     3    4     5    6 
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The pooled fractions on an SDS-PAGE demonstrated an improvement in purification, despite the 
observed faint low molecular weight containments. This protein was cleaned up sufficiently 
allowing the experiment to proceed with crystallization trials.  
3.5 Mass Spectrometry Analysis of Purified BT_0339 
Analysis of BT_0339 was completed prior to initiation of enzyme assays and crystallization trials in 
order to ensure the identity of the protein of interest is that of the prediction. The expected size of 
the purified protein was approximated to be 87968Da and mass spectrometry results confirmed the 
weight was 87970Da. Mass spectrometry generally can provide an error rate of ~1-3 Daltons
57
, 
demonstrating that the purified protein was the predicted α-glucosidase, BT_0339 (Figure 3.15). 
 
 
Figure 3.15 Mass Spectrometry analysis for BT_0339-29a. Highlighted mass was the observed 





3.6 Enzyme Kinetics of BT_0339 
Glucose-oxidase assay was initially performed on BT_0339-29a with maltose as a substrate. 
BT_0339 was observed to successfully hydrolyze the α-(1,4) linkages of maltose and liberate free 
glucose (Figure 3.16). However, it was also observed that the rate of which this enzyme was able to 
hydrolyze maltose was quite slow. Due to limitations with the substrate solubility, Vmax could not 
be determined and therefore, the Km could not be reported by the Michaelis-Menten equation.  
 
Figure 3.16 Hydrolytic activity of BT_0339 with maltose as a substrate. Assay was completed 
in a range of substrate concentrations of 2 to 200mM. 
Hydrolytic ability on additional substrates was also investigated in order to determine the specifics 































substrate over maltose, demonstrating that is preferentially cleaves α-(1,6) over α-(1,4) linkage. 
Additionally, it was observed that BT_0339 prefers a substrate that is longer in length when 
comparing the levels of released glucose for the maltose derivative substrates. Also, BT_0339 was 
unable to utilize sucrose or lactose as a substrate. These results also indicate that BT_0339 does not 
preferentially cleave maltohexaose, demonstrating a level of cleavage that is slightly above the 
background level. The observed low activity of this enzyme resulted in a maximum substrate 
concentration of 30-50mM being assessed, due to restrictions with substrate availability. This 
limitation allowed for the calculation of the linear portion of the kinetic curve but the inability to 
report the Vmax and Km (refer to Supplementary Data).  
 
Figure 3.17 Glucose-oxidase assays for BT_0339 with isomaltose, maltooligosaccharides, 
lactose and sucrose. Values derived from kinetic plots for each individual substrate at a 
























































































































As mentioned, two constructs of BT_0339 were created in vectors pET-29a and 15b. Both of the 
enzymes expressed by these constructs were assessed for enzymatic ability on maltose as a 
substrate, with a range of concentrations, 2-200mM (Figure 3.18). It was found that the selection of 
vector had no significant impact on the functionality of the enzyme BT_0339 with observed an 
similar curves for both constructs. Deviations between the vectors in relation to the catalytic 
efficiency of these enzymes was comparable and the assessment of 30mM of maltose revealed that 
the catalytic efficiency for BT_0339-29a was 1.4uM and for BT_0339-15b was 1.1uM.  
 
Figure 3.18 Analysis of vector selection for BT_0339 with maltose as a substrate. Comparison 
of vector selection was completed with vector pET-29a is shown in the above figure by the circled 
curve and vector pET-15b is indicated by the square curve. 
Additionally, the pH of the assay for BT_0339 was assessed and demonstrated no significant 

































3.7 Purification of BT_3299  
The additional α-glucosidase, BT_3299, was purified by affinity chromatography, using NTA-Ni 
resin. Fractions were collected and run on an SDS-PAGE for comparison (Figure 3.19). BT_3299 
was successfully eluted off at 100mM imidazole elution and fractions were pooled, yielding a 
significant amount of protein.  
.  
Figure 3.19 Affinity Purification of BT_3299 with Ni-NTA resin. Lane 1 is the protein ladder, 
lane 2 is the flow through, lane 3 and 4 is wash 1 and 2 respectively, lane 5 is 25mM elution, lane 6 
is 50mM elution, lane 7 is 100mM elution, lane 8 is 200mM elution, lane 9 is 250mM elution and 
lane 10 is 500mM elution of imidazole. 
The pooled sample for BT_3299 was further purified by FPLC with an anion exchange column. 








Figure 3.20 FPLC Purification of BT_3299 by anion exchange. Exchange was completed with 
an  elution gradient of 0-100% 1M NaCl. Indicated region were the elution fractions that were 
pooled. 
It was demonstrated that an initial slender peak came off the anion exchange column, which was 
presumed to be the protein of interest. Fractions 17 to 20 were pooled together and were run on an 
SDS-PAGE, along with the other fractions for confirmation purposes (Figure 3.21). 
 
Figure 3.21 SDS-PAGE analysis of FPLC Purification fractions for BT_3299. Lane 1 is fraction 
21, lane 2 is fraction 22, lane 3 is fraction 23, lane 4 is fraction 24, lane 5 is fraction 25, lanes 6 to 8 
is dilution series of the pooled fractions 17-20 and lane 9 is a protein ladder.  
1    2   3   4  5   6   7   8  9 
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Pooled fractions 17-20 revealed a significantly purified sample, with reduced level of contaminates. 
This pooled sample was of enough homogeneity to initiate crystallization trials. Previous studies of 
BT_3299 completed a Mass Spectrometry analysis on the purified enzyme and reported the purified 
product was the predicted protein, BT_3299
49
. 
3.8 Enzyme Kinetics of BT_3299 
Substrate specificity of BT_3299 was assessed in the same manner as BT_0339. The initial 
substrate assessed was maltose in a concentration range of 2-200mM. Results were fit to a 
Michaelis-Menten curve in attempts to define the Vmax and Km (Figure 3.22).
 
Figure 3.22 Hydrolytic activity of BT_3299 with maltose as a substrate. Assay was completed 
































It was revealed that there was a similar mechanism for BT_3299 as observed for BT-0339 for 
maltose as a substrate. BT_3299 was successfully able to cleave the α-(1,4) bond between the 
residue, releasing free glucose. Similarly, BT_3299 hydrolytic capabilities on maltose was at a slow 
rate and due to the limitations of substrate solubility, it was not possible to determine an accurate 
Vmax or Km. Substrate specificity was further investigated with the assessment of  isomaltose, 
maltose derivatives, lactose and sucrose as substrates (Figure 3.23).  
 
 
Figure 3.23 Glucose-oxidase assay for BT_3299 with isomaltose, maltooligosaccharides, 
lactose and sucrose. Values were obtained from kinetic plots for each substrate and plotted at a 
concentration of 30mM. 
It was observed that the specificity of BT_3299 is similar to that of BT_0339, preferring isomaltose 






























































































































observed higher activity on maltotetraose and maltoheptaose. BT_3299 was unable to utilize 
sucrose or lactose as substrate and release free glucose revealing its lack of specificity for these 
substrates. It was also shown that BT_3299 does not cleave glucose residue from maltohexaose 
polymer, demonstrating a similar specify observed for BT_0339. 
The pH of the assay was previously assessed for BT_3299 and was found to demonstrate its optimal 




3.9 Operon Prediction for BT_0339 
Operon prediction was completed for the gene bt_0339 using the program MicrobeOnline. The gene 
bt_0339 was predicted to be part of an operon consisting of multiple genes (Figure 3.24). 
 
 
Figure 3.24 Predicted operon for the gene bt_0339. The query gene is indicated by the darker 
blue colour, nearby genes that are predicted to be part of the same operon are in light blue and genes 
upstream/downstream of operon are in white. The arrowhead indicates the direction of transcription 
and the numbers are the intragenic distance between the two adjacent genes
53
. 
A number of genes were predicted to be part of the operon of that bt_0339 is predicted to be a 
member (Table 3.1). The predicted operon for BT_0339 consists of pectin lyases fold/virulence 




Table 3.1 Genes predicted to be part of the operon for bt_0339. 
Gene Protein Name 
bt_0338 pectin lyase fold/virulence factor 
bt_0339 alpha-glucosidase 
bt_0340 trimethylamine coronoid protein 2 
bt_0341 Na+/glucose co-transporter 
 
3.10 Operon Prediction for BT_3299 
The operon of bt_3299 was also predicted using the program MicrobeOnline
53
 (Figure 3.25).  
 
 
Figure 3.25 Predicted operon for the gene bt_3299. The query gene is indicated by the arker blue 
colour, nearby genes that are predicted to be part of the same operon are in light blue and genes 
upstream/downstream of operon are in white. The arrowhead indicates the direction of transcription 
and the numbers are the intragenic distance between the two adjacent genes
53
. 
There were also a number of genes predicted to be part of the operon of bt_3299 in comparison with 
that of bt_0339 (Table 3.2). A few of the genes were predicted to be glycoside hydrolases that 
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would be assumed to have their function independent of that of bt_3299. Yet, there are homologs of 
Sus proteins that have been shown to be related to the function of utilizing polymers of starch.  
Table 3.2 Genes predicted to be part of the operon for bt_3299. 
Gene Protein 
bt_3295 hypothetical protein 
bt_3296 Outer membrane protein: SusD homolog 
bt_3297 hypothetical protein: SusC homolog 
bt_3298 
hypothetical protein with a conserved domain-cell 
surface receptor 
bt_3299 α-glucosidase II 
bt_3300 β-glucosidase 
 
3.11Crystallization Trials for BT_0339 
Crystallization trials were completed on both constructs of BT_0339. Hampton Research Index
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screen was the first screen used for both of these enzymes. The Index Screen for BT_0339-29a was 





Table 3.3 Initial crystallization hits for BT_0339-29a. Screen was completed with the Hampton 
Research Index Screen. 
Reagent 
# 
Salt Buffer Precipitant 
72 0.2M Sodium chloride 0.1M Hepes, pH 7.5 25% Polyethylene glycol 3,350 
80 0.2M Ammonium acetate 0.1M Hepes, pH 7.5 25% Polyethylene glycol 3,350 
 
The Index Screen for BT_0339-15b was also observed to produce a number of positive hits that 
were further investigated for optimization (Table 3.4). 
 
Table 3.4 Initial crystallization hits for BT_0339-15b. Screen was completed with the Hampton 
Research Index Screen. 
Reagent 
# 
Salt Buffer Precipitant 
72 0.2M Sodium chloride 0.1M Hepes, pH 7.5 25% Polyethylene glycol 3,350 
79 0.2M Ammonium acetate 
0.1M Bis-Tris, pH 
6.5 
25% Polyethylene glycol 3,350 
81 0.2M Ammonium acetate 0.1M Tris, pH 8.5 25% Polyethylene glycol 3,350 
 
Custom optimization screens were set up for the positive hits observed in the Index screen. These 
optimized conditions varied in in pH, concentration of salt, precipitant and buffer components and 
concentration as related to the initial screen. These conditions resulted in an improved number of 
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conditions with crystal growth and the type of crystals that formed. However, it appeared that 
majority of the conditions resulted in poor lattice formation resulting in twinned crystals (Figure 
3.26 and 3.27) 
 
Figure 3.26 Crystallization of BT_0339-29a in an optimized condition.  
 
 
Figure 3.27 Crystallization of BT_0339-15b in an optimized condition.  
Further optimized conditions consisted of the addition of additives to both BT_0339 constructs. 
These small molecules were added to some of the previously optimized conditions that were 
observed to have reasonably sized crystals. BT_0339-15b did not lead to much better conditions 
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with the addition of the additives, whereas BT_0339-29a resulted in a number of conditions 
yielding much better quality crystals that were attractive to screen for diffraction (Figure 3.28). 
These conditions consisted of 0.2 M ammonium acetate, 0.2M Hepes, pH 7.5 and 15% PEG 3350 
(GH Screen-19) with the separate addition of the additives 0.1M calcium acetate hydrate, 0.1 M 
calcium chloride dehydrate and 0.1 M urea.  
 
 
Figure 3.28 Crystallization of BT_0339-29a in GH Screen-19 with urea as an additive. 
These conditions for BT_0339-29a were screened for quality of diffraction. All the crystals 
screened produced some degree of diffraction; however, they produced only low resolution 




Figure 3.29 Diffraction image for BT_0339-29a. Crystal was grown in the optimized condition of 
GH Screen-19 with urea as an additive. 
 
3.12 Crystallization trials of BT_3299 
Crystallization of BT_3299 was also completed initially with the Hampton Research Index screen 
and a number of conditions produced successful conditions worth optimizing (Table 3.5).  
Table 3.5 Initial crystallization hits for BT_3299. Screen was completed with the Hampton 
Research Index Screen 
Reagent # Salt Buffer Precipitant 
61 0.2M L-Proline 0.1M Hepes, pH 7.5 10% Polyethylene glycol 3,350 
68 0.2M Ammonium sulfate 0.1M Hepes, pH 7.5 25% Polyethylene glycol 3,350 




These conditions were then further optimized by custom optimization screens. These screens 
consisted of optimizing pH, concentration of salt, precipitant and buffer, and buffer composition in 
relation to the initial condition. The index screen produced crystals that were poor quality, mainly 
consisting of plate clusters. The optimized conditions allowed for the growth of better quality 
crystals that were diamond shape, but majority of these had some degree of twinning characteristic 
(Figure 3.30).  
 
Figure 3.30 Crystallization of BT_3299 enzyme in an optimized condition. 
Addition of additives to these conditions was then pursued, resulting in less twinned crystals.  A 
condition consisting of 0.2 M sodium chloride, 0.2 M Tris-HCl, pH 7.5, 15% PEG 3350 (GH 




Figure 3.31 Crystallization of Bt_3299 in GH Screen-31 with the additive 0.1 M calcium 
acetate hydrate.  
This condition resulted in successful protein diffraction but the pattern was fairly high in mosaicity 
and poor resolution (Figure 3.32). 
 
Figure 3.32 Diffraction image for BT_3299. Crystal was grown in the optimized condition of GH 










4.1 Results and their Implications 
Recent research has illustrated the significant impact microorganisms can have on humans and their 
ability to influence our wellbeing. These microbial cells populate the human body in numbers that 
exceed our own cells and have been shown to affect various human biological processes that range 
from nutritional, developmental and immunological. Microorganisms that reside in the 
gastrointestinal tract thrive in a specific niche that has direct interaction with the human host and are 
present in significantly high numbers. Specifically, the colon demonstrates an environment that is 
highly favourable for the establishment of these indigenous organisms, where they have been 
observed to contribute to nutrition by utilizing indigestible dietary plant polysaccharides
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As highlighted, a particular member of the colon microbiota that is of significant interest in relation 
to human digestion is Bacteroides thetaiotaomicron. This anaerobic bacterium is one of the 
dominant members of the colon region and has been shown to potentially perform biological 
activities that can contribute to the human host’s nutrition. Predicted proteins from the sequenced 
genome revealed this organism is highly capable of utilizing various forms of polysaccharides and 
possesses a noteworthy number of glycoside hydrolases. Investigation of the function and structure 
of these hydrolases can reveal specific processes that this organism is capable of completing that 
can influence the physiology of the host.  
This report investigated the functionality of two α-glucosidases from the Family 31 Glycoside 
Hydrolase from the bacterium Bacteroides thetaiotaomicron. These two enzymes were predicted to 
cleave glucose residues from the terminal end of starch polymers. Kinetic studies of the α-
glucosidase, BT_0339, revealed it has a substrate specificity that is interestingly varied from the 
predicted function. It was observed that BT_0339 preferred isomaltose over maltose as a substrate, 
revealing this enzyme’s preference to cleave an α-(1,6) linkage over an α-(1,4) linkage. When 
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assessing maltooligosaccharides it was observed that BT_0339 also prefers substrates that are 
longer in length. There was an observed correlation between the increase in moles of glucose 
provided in the substrate and the level of glucose liberated. It can be predicted that a longer 
substrate is better accommodated in the enzyme, resulting in a more effective mechanism of 
cleavage. However, one inconsistency in the data was observed with maltohexaose as a substrate, 
where BT_0339 was unable to cleave glucose at a level that is proportionate to its length. This 
result may reflect a possible secondary structure that maltohexaose is able to form in solution, 
which may slow down the hydrolytic activity of BT_0339 on this substrate. BT_0339 is also unable 
to utilize sucrose or lactose as a substrate, further demonstrating that this enzyme favours an α-(1,4) 
linkage with the polymer composed of repetitive units of glucose. Kinetic properties of BT_0339 
showed low activity against the provided substrates resulting in the inability to accurately calculate 
the Vmax or Km for each substrate. Despite the limited catalytic activity of this enzyme it was 
demonstrated to hydrolyze various starch derived substrates.  
Kinetic parameters of BT_3299 were investigated using the glucose-oxidase assay and it was 
observed to prefer isomaltose over maltose as a substrate, revealing a similar preference for an α-
(1,6) linkage over an α-(1,4) linkage. Assessment of the hydrolytic activity of BT_3299 on various 
maltose derived substrates revealed this enzyme prefers maltoheptaose followed by maltotetraose as 
a substrate. These kinetic observations suggest that these specific substrates form a secondary 
structure or complex in solution that is optimal for BT_3299 to hydrolyze. Similarly, it was 
observed that BT_3299 hydrolyzed maltohexaose at an unexpectedly slow rate, which can also 
reflect the possible limitation this enzyme has at accessing this substrate in solution. Kinetic data for 
the Km and Vmax for the provided substrates could not be reported for BT_3299, as a result of the 
limited activity and the restricted availability of some of the maltose derived substrates. However, 
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the hydrolytic ability of this enzyme in the performed assays reveals its ability to utilize various 
starch derived substrates.  
The kinetic patterns of the hydrolytic activity of both α-glucosidases as observed in these assays are 
quite comparable, yet are they a true representation of their activity in the environment of the 
human colon? A degree of understanding can come from comparing the kinetic properties of these 
enzymes with those obtained in a similar study involving a Family 31 α-glucosidase from 
Ruminococcus obeum, a common member of the gut microbiota. Substrate kinetics for this α-
glucosidase (RUMOBE_03919) revealed a similar low level of hydrolytic activity on the provided 
starch derived substrates. Kinetic analysis of RUMOBE_03919 was assessed using the glucose-
oxidase assay and it was reported that this enzyme had a substrate preference for isomaltose over 
maltose, revealing specificity for α-(1,6) over α-(1,4) glycosidic linkage. Comparison of various 
substrates including maltose derivatives resulted in a distinct profile of this enzyme’s substrate 
preference. Kinetic data revealed the highest level of hydrolytic activity was on isomaltose at 
40mols of glucose cleaved per min per mol of enzyme in the reaction. Maltose was observed to 
have 25mols of glucose cleaved per min per mol of enzyme in the reaction. In comparison, 
BT_0339 yielded the following values: for maltoheptaose at 270, isomaltose at 200 and maltose at 
120mols of glucose cleaved per min per mol of enzyme in the reaction. BT_3299 was observed to 
have maltoheptaose at 270, maltotetraose at 250 and isomaltose at 200mols of glucose cleaved per 
min per mol of enzyme. In general, the catalytic efficiency of BT_0339 and BT_3299 is comparable 
to that of the Ruminococcus obeum enzyme. This comparison highlights that perhaps this level of 
cleavage by these microbial Family 31 Glycoside Hydrolases is a true representation of hydrolysis 
of starch substrates in the colon. Interestingly, the kinetic patterns that were observed suggest that 
though these enzymes have a similarity in how they function, it is evident that they have specific 
characteristics that define their activity. This specificity can be reflected in the amino acid 
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composition of these enzymes and the slight differences in their predicted signature catalytic 
sequences. Furthermore, it can be assumed that there is slight amino acid variation in the active site 
of these enzymes, which allows for the slight variations in the observed substrate specificity 
amongst these Family 31 enzymes. 
When assessing the functionality of these enzymes, it is important to also consider the collective 
effect they may have on the host in addition to assessing them on an individual basis. The 
implications of the identified starch utilization ‘like’ systems in Bacteroides thetaiotaomicron 
demonstrates that though these enzymatic systems may function independently, they may also be 
simultaneously regulated. The identification of over 80 Polysaccharide Utilization Loci also 
provides insight into that a combination of these systems can lead to a significant multi-enzymatic 
system that is capable of degrading starch. If the products of these loci are a summed process, then 
it can be assumed that ultimately they can have a significant effect on the human host. In the 
process of liberating free glucose for its own energy requirements, Bacteroides thetaiotaomicron 
indirectly releases this simple sugar to the surrounding environment and undoubtedly can be taken 
up by surrounding bacteria in the lumen, as well as by the host intestinal epithelia. Accepting the 
connection between BT_0339 and BT_3299 with the human host suggests that though these 
enzymes have an observed low level of activity, they are also capable of exerting an influence on 
the host’s metabolism and energy levels. Furthermore, the function of these enzymes can potentially 
influence the ability of other residing microbes to flourish in the colon, which likewise, affects the 
host.  
Assessing BT_0339 and BT_3299 and its constitutive operons revealed interesting information and 
additional proteins that are relevant to the ability of these enzymes to utilize starch derived 
substrates.  BT_0339 was found to have multiple proteins in its operon, including a pectin lyase 
fold/virulence factor, a trimethylamine corrinoid protein 2 and a Na+/glucose co-transporter. The 
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pectin lyase fold/virulence factor and trimethylamine corrinoid protein 2 appear to have no obvious 
function that is relatable to BT_0339. However, the Na+/glucose co-transporter is one component 
that appears to be highly relatable to the function of BT_0339. This transporter is predicted to 
function by an ion gradient that allows for an active transport. A generated high concentration of 
Na+ on the outside of the bacterial cell creates a favourable gradient for transporting Na+ into the 
cell, which in-turn pumps glucose into the bacterial cell. Interestingly, this type of protein is found 
in the intestinal mucosa of the small intestine and enables free glucose to be transported into the 
blood stream from the intestinal lumen
58
. Assuming this is the mechanism that this transporter 
performs, it is plausible that BT_0339 acts as a glycoside hydrolase in the lumen outside the 
bacterial cell. With this assumption, BT_0339 cleaves starch and releases free glucose, which is 
then transported into the bacterial cell by the transporter and is utilized for energy. Based on the 
functionality of this transporter, it can be suggested that at a certain level the transporter would 
become saturated with glucose and would be unable to transport these molecules into the bacterial 
cell, resulting in free glucose in the lumen. With that, it can also be assumed that some proportion 
of the free glucose is transported into the blood stream by the human host’s intestinal transporters. 
Based on the results from the enzymatic kinetic analysis, this effect can be assumed to be quite 
minimal, but nonetheless, it is could be a contributing factor to glucose uptake in the colon by the 
human host. Additionally, the functionality of BT_0339 may be tied into a dual functioning with the 
transporter. It is possible that there is a requirement for these proteins to work in unison in order to 
demonstrate the full functioning capability of BT_0339. These proteins maybe tethered to the 
membrane and the presence of one enhances the abilities of the other. However, this type of 
analysis is beyond the scope of this project. 
Predicted operon analysis of BT_3299 revealed an operon composed of multiple proteins. This 
predicted operon contains multiple glycoside hydrolases, Sus-like proteins and a cell surface 
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receptor. These results were compared to those reported in a previous study where PUL’s were 
identified in Bacteroides thetaiotaomicron and interestingly it was found that BT_3299 was a 
member of PUL #55 (Table S2 in Supplementary Data)
42
. This predicted operon reveals multiple 
glycoside hydrolases and proteins that were characterized as Sus homologs. PUL #55 consists of a 
SusD and SusC homologs, as well as a two component system regulator. These predicted proteins 
illustrate that BT_3299 is a member of an organized system and functions in a manner related to 
these proteins. Based on the predicted function of these proteins in comparison with the previously 
characterized Starch Utilization System, it is assumed that the SusD-like protein binds a starch 
polymer and a degree of cleavage occurs by an uncharacterized glycoside hydrolase. The liberated 
short polymers of glucose or single glucose molecules are transported into the bacterial cell by the 
SusC-like protein and are further cleaved into simple sugars within the periplasm. These simple 
sugars are available to the cell for energy and also act as to induce expression of the entire system, 
as detected by the two-component system regulator. The predicted function of this operon follows 
the basis of the Sus-like paradigm. This operon does not highlight whether BT_3299 would be 
found residing in the lumen, tethered to the membrane or found in the periplasm. However, it does 
reveal that a starch polymer is predicted to be cleaved outside of the cell and then transported into 
the cell. Similarly to BT_0339, a proportion of the cleaved glucose molecules will be in the colon 
lumen and are assumed to be available to be utilized by the surrounding microbiota and the human 
host.  
Crystallization of these enzymes was initiated and significant progress has been made towards data 
collection. BT_0339 was optimized in a condition that was altered by a slight decrease in the level 
of PEG and the addition of an additive. Similarly, the optimized condition of BT_3299 also 
consisted of a decreased amount of PEG and the addition of an additive. Both of these altered 
factors enabled a condition that allowed for the protein molecules to able to form a more organized 
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lattice. Initial, screening of diffraction patterns resulted in poor diffraction data with mainly low 
resolution and high mosaic images. It can be assumed that though the protein molecules are able to 
form a lattice there is still a degree of disorder in the crystal formation. In order to achieve better 
quality data there are multiple avenues to pursue to determine the influence causing the mosaicity. 
Flash cooling the crystals can have an effect on the mosaicity, as a result of the mother liquor 
freezing and cracking which can create disorder within the crystal. Optimizing the amount of liquid 
surrounding the crystal or dehydrating it can possibly provide an improvement in the diffraction 
data. Investigation of the type of cyro-protectant solution used in freezing these crystals could also 
provide better diffraction patterns. Sometime mosaicity cannot be avoided due to the fact it is a 
characteristic of how the crystal lattice forms therefore, further investigating additives that allow for 
three dimensional crystal formations can perhaps provide better diffraction. Simply, another 
solution to obtaining good quality diffraction data is to continually screen the optimized condition 




4.2 Future Directions 
It would be interesting to further investigate the substrate specificity of these enzymes and further 
define their abilities to utilize longer oligosaccharides derived from isomaltose. There are 
limitations in purchasing isomaltose-derived substrates, which reflects the reason for only using 
isomaltose in this study. However, an interesting substrate worth pursing is limit dextrins, which are 
derivatives of starch that enter the colon after small intestinal enzymatic degradation. Limit dextrins 
are mainly composed of α-(1,4) linked glucose with periodic branched α-(1,6) linkages that will 
vary due to the source of the originally ingested starch polymer.  Investigating a variety of limit 
dextrins may provide additional information regarding substrate specificity of these enzymes and 
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particularly address their ability to utilize the maltose-derived substrates at differing rates. 
Furthermore, having knowledge of the original nutritional source of these limit dextrins can provide 
a degree of understanding of specifics components of the human diet that these enzymes are able to 
utilize. Limit dextrins from a variety of sources are available to us through our collaboration with 
Dr. Bruce Hamaker (Purdue).  
Further understanding the predicted operons and how they function can increase the understanding 
of these enzymes. It is unknown at this point how the components of both operons function and 
behave structurally, yet their presence is highly related to how BT_0339 and BT_3299 perform. 
Additionally, it is unclear whether these proteins are under individual control or if a promoter 
controls them collectively. Completing mutation studies of these operons can reveal whether their 
functionality is reflected in the survival of this organism and if they are related to one another. This 
type of analysis can possibly render information regarding these enzymes functioning in a collective 
manner. Also, assessing the proteins from the operons on an individual level will provide an 
understanding of how these α-glucosidases function in-vivo and in relation to the human host. 
Continued investigation of the optimal condition for diffraction for both enzymes can potentially 
lead to conditions that will allow for the collection of good quality data. The structure of these 
enzymes can divulge structural information about the active site and reveal how their structure is 
relatable to their function. Additionally, structures of these enzymes can possibly provide 
information regarding their functionally on the substrates assessed in this study and further illustrate 
the hydrolytic abilities of these enzymes on starch derived substrates. Soaking a substrate into the 
crystal can reveal specifics about the interaction between the substrate and the active site. It can 
visually demonstrate how these enzymes demonstrate the observed substrate specificity. This 
information can possibly be used to complement the kinetic properties observed in this study and 
further support the functionality of these enzymes in the relation to Bacteroides thetaiotaomicron.  
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It is quite apparent through many completed studies that Bacteroides thetaiotaomicron is an 
organism that possesses specific characteristics that have enabled it to establish its dominant role in 
the colon microflora. Accumulating evidence further demonstrates that this organism has a 
multitude of glycoside hydrolyses that enables it to utilize the various undigested polysaccharides 
passing through the colon. Specifically, it has been shown in this report that this organism has 
multiple functional glycoside hydrolyses that are members of the Family 31 Glycoside Hydrolase. 
This report has demonstrated through kinetic analysis that these enzymes are able to use various 
derivatives of starch and release free glucose. It is hypothesized that these released glucose 
molecules are able utilized by the organism, but also, are free to be used by surrounding 
microorganisms and as well as the human host. These results reveal a small but significant role that 
Bacteroides thetaiotaomicron has in contributing to the human host’s nutrition and energy levels. 
Further investigation of these enzymes structurally and their functional operon counterparts can 
provide additional information regarding the role of this organism as a starch degrader. Ultimately, 
this knowledge can help us to understand the colon microbiota that has the ability to strongly 











The kinetics for the enzymes BT_0339 and BT_3299 were completed on various substrates in 
addition to maltose. These assays were completed in a range of substrates and the data was fitted to 
a Michaelis-Menten plot.  
 
Figure S1 Michaelis-Menten plot for BT_0339 with maltotriose as the substrate. Assay was 


































igure S2 Michaelis-Menten plot for BT_0339 with maltotetraose as a substrate. Assay was 
completed with substrate in the range of 1-50mM 
.  
Figure S3Michaelis-Menten plot BT_0339 with maltopentaose as a substrate. Assay was 



































































Figure S4 Michaelis-Menten plot for BT_0339 with maltohexaose as a substrate. Assay was 
completed with substrate in the range of 1-30mM. 
 
 
Figure S5 Michaelis-Menten plot for BT_0339 with maltoheptaose as a substrate. Assay was 














































Figure S6 Michaelis-Menten plot for BT_0339 with isomaltose as a substrate. Assay was 
completed with substrate in the range of 2-100mM. 
 
 
Figure S7 Michaelis-Menten plot for BT_0339 with lactose as a substrate. Assay was completed 

































































Figure S8 Michaelis-Menten plot for BT_0339 with sucrose as a substrate. Assay was 
completed with substrate in the range of 2-200mM. 
 
 
Figure S9 Michaelis-Menten plot for BT_3299 with maltotriose as a substrate. Assay was 






























































Figure S10 Michaelis-Menten plot for BT_3299 with maltotetraose as a substrate. Assay was 
completed with substrate in the range of 1-50mM. 
 
 
Figure S11 Michaelis-Menten plot for BT_3299 with maltopentaose. Assay was completed with 


































































Figure S12 Michaelis-Menten plot BT_3299 with maltohexaose as a substrate. Assay was 
completed with substrate in the range of 1-30mM. 
 
 
Figure S13 Michaelis-Menten plot BT_3299 with maltoheptaose as a substrate. Assay was 

































































Figure S14 Michaelis-Menten plot BT_3299 with isomaltose as a substrate. Assay was 
completed with substrate in the range of 2-100mM. 
 
 
Figure S15 Michaelis-Menten plot for BT_3299 with lactose as a substrate. Assay was 





























































Figure S16 Michaelis-Menten plot for BT_3299 with sucrose as a substrate. Assay was 








































Table S1 Catalytic ability of BT_0339 and BT_3299 on various substrates. 
 
V/K 
Substrate BT_0339 BT_3299 
Maltose  0.00151 ±4.8E-05 0.00113±6.7E-05 
Isomaltose 0.00217±2.8E-05 0.00206±1.6E-04 
Malotriose 0.00046±1.0E-04 0.00061±2.3E-05 
Maltotetraose 0.00114±5.0E-05 0.00252±1.7E-05 
Maltopentaose 0.00187±1.2E-04 0.00173±6.4E-05 
Maltohexaose 0.00041±1.7E-05 0.00051±6.6E-05 
Maltoheptaose 0.00300±4.8E-04 0.00272±3.0E-04 
Sucrose 0.00039±1.5E-05 0.00059±6.7E-06 
Lactose 0.00012±1.2E-05 0.00058±4.1E-07 
 
Table S2 Polysaccharide Utilization Loci # 55 for Bacteroides thetaiotaomicron. 
Gene Protein Name 
bt_3292 β-glucosidase 
bt_3293 β-galatosidase 
bt_3294 β-glucosidase  
bt_3295 Hypothetical protein 
bt_3296 SusD-like 
bt_3297 SusC-like 
bt_3298 Hypothetical protein 
bt_3299 α-glucosidase 
bt_3300 β-glucosidase 
bt_3301 α-1,6 mannase 
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